Skip to content

Net Income at other companies

Eli Lilly logo
Eli LillyLLY
$7.4B+168%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$5.24B-52.4%
Amgen logo
AmgenAMGN
$1.82B+5.1%
AbbVie logo
AbbVieABBV
$695M-46.0%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
-$19.82M-31.4%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$19.63M-49.3%

Segments

By segment

See full
Reportable Segment-$14.77M-7.8%

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s net income?
Shattuck Labs, Inc. (STTK) reported net income of -$14.77M in Q1 2026.
How has Shattuck Labs, Inc.'s net income changed year-over-year?
Shattuck Labs, Inc.'s net income decreased by 7.8% year-over-year, from -$13.7M to -$14.77M.
What is the long-term trend for Shattuck Labs, Inc.'s net income?
Over 3 years (2022 to 2025), Shattuck Labs, Inc.'s net income has grown at a -21.8% compound annual growth rate (CAGR), from -$101.95M to -$48.81M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.